192 related articles for article (PubMed ID: 37366903)
21. Patterns of care and survival outcomes of palliative radiation for prostate cancer with bone metastases: comparison of ≤5 fractions to ≥10 fractions.
Schreiber D; Safdieh J; Becker DJ; Schwartz D
Ann Palliat Med; 2017 Jan; 6(1):55-65. PubMed ID: 28209069
[TBL] [Abstract][Full Text] [Related]
22. Outcomes for pediatric patients with osteosarcoma treated with palliative radiotherapy.
Chen EL; Yoo CH; Gutkin PM; Merriott DJ; Avedian RS; Steffner RJ; Spunt SL; Pribnow AK; Million L; Donaldson SS; Hiniker SM
Pediatr Blood Cancer; 2020 Jan; 67(1):e27967. PubMed ID: 31407520
[TBL] [Abstract][Full Text] [Related]
23. Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019).
James ND; Spears MR; Clarke NW; Dearnaley DP; De Bono JS; Gale J; Hetherington J; Hoskin PJ; Jones RJ; Laing R; Lester JF; McLaren D; Parker CC; Parmar MKB; Ritchie AWS; Russell JM; Strebel RT; Thalmann GN; Mason MD; Sydes MR
Eur Urol; 2015 Jun; 67(6):1028-1038. PubMed ID: 25301760
[TBL] [Abstract][Full Text] [Related]
24. Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies.
Gravis G; Boher JM; Chen YH; Liu G; Fizazi K; Carducci MA; Oudard S; Joly F; Jarrard DM; Soulie M; Eisenberger MJ; Habibian M; Dreicer R; Garcia JA; Hussain MHM; Kohli M; Vogelzang NJ; Picus J; DiPaola R; Sweeney C
Eur Urol; 2018 Jun; 73(6):847-855. PubMed ID: 29475737
[TBL] [Abstract][Full Text] [Related]
25. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy.
Henkenberens C; Oehus AK; Derlin T; Bengel F; Ross TL; Kuczyk MA; Janssen S; Christiansen H; von Klot CAJ
Strahlenther Onkol; 2020 Nov; 196(11):1006-1017. PubMed ID: 32399639
[TBL] [Abstract][Full Text] [Related]
27. Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists.
Chow E; Danjoux C; Wong R; Szumacher E; Franssen E; Fung K; Finkelstein J; Andersson L; Connolly R
Radiother Oncol; 2000 Sep; 56(3):305-14. PubMed ID: 10974379
[TBL] [Abstract][Full Text] [Related]
28. Eastern Cooperative Oncology Group Performance Score Is Associated With Survival After Radiotherapy of Bone Metastases from Prostate Cancer.
Haus R; Janssen S; Schild SE; Rades D
In Vivo; 2020; 34(2):679-682. PubMed ID: 32111769
[TBL] [Abstract][Full Text] [Related]
29. Survival After Palliative Radiotherapy in Patients with Breast Cancer and Bone-only Metastases.
Nieder C; Dalhaug A; Pawinski A; Mannsåker B; Haukland E
In Vivo; 2016 11-12; 30(6):879-883. PubMed ID: 27815475
[TBL] [Abstract][Full Text] [Related]
30. FDG-PET Predicts Pain Response and Local Control in Palliative Radiotherapy With or Without Systemic Treatment in Patients With Bone Metastasis From Non-small-cell Lung Cancer.
Zhao F; Ding G; Huang W; Li M; Fu Z; Yang G; Kong L; Zhang Y; Yu J
Clin Lung Cancer; 2015 Nov; 16(6):e111-9. PubMed ID: 25736696
[TBL] [Abstract][Full Text] [Related]
31. The influence of breast cancer subtype on survival after palliative radiation for osseous metastases.
Abdelhakiem MK; Johnstone C; Bergom C; Currey A; Robbins JR
Cancer Med; 2020 Dec; 9(23):8979-8988. PubMed ID: 33146466
[TBL] [Abstract][Full Text] [Related]
32. Patient-reported symptoms before palliative radiotherapy predict survival differences.
Nieder C; Kämpe TA; Pawinski A; Dalhaug A
Strahlenther Onkol; 2018 Jun; 194(6):533-538. PubMed ID: 29344766
[TBL] [Abstract][Full Text] [Related]
33. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer with low burden skeletal disease at diagnosis: outcome of concomitant radiotherapy on primary tumor and metastases.
Deantoni CL; Fodor A; Cozzarini C; Fiorino C; Brombin C; Di Serio C; Calandrino R; Di Muzio N
Br J Radiol; 2020 Apr; 93(1108):20190353. PubMed ID: 31971828
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcomes of combining prostate brachytherapy and metastasis-directed radiotherapy in newly diagnosed oligometastatic prostate cancer: A retrospective cohort study.
Tsumura H; Ishiyama H; Tabata KI; Sekiguchi A; Kawakami S; Satoh T; Kitano M; Iwamura M
Prostate; 2019 Apr; 79(5):506-514. PubMed ID: 30585345
[TBL] [Abstract][Full Text] [Related]
36. Palliative radiation therapy in patients with metastasized pancreatic cancer - description of a rare patient group.
Habermehl D; Brecht IC; Debus J; Combs SE
Eur J Med Res; 2014 May; 19(1):24. PubMed ID: 24887532
[TBL] [Abstract][Full Text] [Related]
37. Stability and survival analysis of elderly patients with osteolytic spinal bone metastases after palliative radiotherapy : Results from a large multicenter cohort.
Bostel T; Förster R; Schlampp I; Sprave T; Akbaba S; Wollschläger D; Debus J; Mayer A; Schmidberger H; Rief H; Nicolay NH
Strahlenther Onkol; 2019 Dec; 195(12):1074-1085. PubMed ID: 31240346
[TBL] [Abstract][Full Text] [Related]
38. Early palliative radiation therapy in patients with newly diagnosed cancer: Reasons, clinical practice, and survival.
Nieder C; Haukland E; Mannsåker B; Pawinski A; Dalhaug A
Pract Radiat Oncol; 2015; 5(5):e537-e542. PubMed ID: 25823382
[TBL] [Abstract][Full Text] [Related]
39. Use of palliative radiotherapy in brain and bone metastases (VARA II study).
Expósito J; Jaén J; Alonso E; Tovar I
Radiat Oncol; 2012 Aug; 7():131. PubMed ID: 22863023
[TBL] [Abstract][Full Text] [Related]
40. Spinal bone metastases in colorectal cancer: a retrospective analysis of stability, prognostic factors and survival after palliative radiotherapy.
Bostel T; Förster R; Schlampp I; Sprave T; Bruckner T; Nicolay NH; Welte SE; Debus J; Rief H
Radiat Oncol; 2017 Jul; 12(1):115. PubMed ID: 28697786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
